C Russell Trenary III's Net Worth
$2.47 Million
Who is C Russell Trenary III?
C Russell Trenary III has an estimated net worth of $2.47 Million. This is based on reported shares across multiple companies, which include ADVANCED MEDICAL OPTICS INC, and Outlook Therapeutics, Inc..
SEC CIK
C Russell Trenary III's CIK is 0001227307
Past Insider Trading and Trends
2009 was C Russell Trenary III's most active year for acquiring shares with 9 total transactions. C Russell Trenary III's most active month to acquire stocks was the month of January. 2009 was C Russell Trenary III's most active year for disposing of shares, totalling 23 transactions. C Russell Trenary III's most active month to dispose stocks was the month of January. 2009 saw C Russell Trenary III paying a total of $927,930.00 for 104,296 shares, this is the most they've acquired in one year. In 2009 C Russell Trenary III cashed out on 438,948.289 shares for a total of $2,298,737.47, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ADVANCED MEDICAL OPTICS INC No price found
Executive Vice PresidentC Russell Trenary III used to own units in Common Stock but no longer holds any shares there.acquired a total of 130,846 shares in ADVANCED MEDICAL OPTICS INC at a cost of $1,134,700.00, C also disposed a total of 131,607.289 shares of ADVANCED MEDICAL OPTICS INC equalling to $3,241,184.48.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -8.46K |
$22.00 | -$370,228.00 |
0
|
Feb 25 - Feb 26
| |||
Form 4
|
—
|
0
|
$16.32 | -$983,460.00 | 8.46K |
Feb 24
| |||
Form 4
| +10.27% | 4.15K |
$6.29 | -$20,090.26 | 44.54K |
Jan 5 - Jan 5
| |||
Form 4
|
—
|
0
|
$16.60 | -$15,211.90 | 3.95K |
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
$25.10 | -$64,420.00 | 4.21K |
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
| +577.43% | 3.55K |
—
|
—
| 4.16K |
May 24
| |||
Form 4
|
—
|
0
|
$25.67 | -$333,489.00 | 561.51 |
Feb 16
| |||
Form 4
|
—
|
0
|
$24.63 | -$312,750.00 | 509.58 |
Jul 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
| No matching records found | |||||||||
Outlook Therapeutics, Inc. (OTLK) Snapshot price: $7.95
CEO AND PRESIDENTC Russell Trenary III owns 54,925 units of Common Stock which is worth $436,653.75. From 2021 to 2024 C Russell Trenary III acquired a total of 54,925 shares in Outlook Therapeutics, Inc. at a cost of $69,870.50.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 17
| |||
Form 4
| +56.93% | 19.93K |
$1.06 | $21,120.50 | 54.92K |
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
| +250.00% | 25K |
$1.39 | $34,750.00 | 35K |
Dec 6
| |||
Form 4
|
∞
| 10K |
$1.40 | $14,000.00 | 10K |
Dec 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||